RCEL
AVITA Medical·NASDAQ
--
--(--)
--
--(--)
RCEL fundamentals
AVITA Medical (RCEL) Revenue Breakdown: Q3 2025 Business & Regional Performance
AVITA Medical (RCEL) reported total revenue of 17.06M USD in Q3 2025, with its core business segment Commercial Sales contributing 99.62%. Regionally, United States remained the largest market, accounting for 93.96% of total revenue. Explore AVITA Medical's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
AVITA Medical (RCEL) reported total revenue of 17.06M USD in Q3 2025, with its core business segment Commercial Sales contributing 99.62%. Regionally, United States remained the largest market, accounting for 93.96% of total revenue. Explore AVITA Medical's revenue distribution across business segments and global markets to gain insights into its growth trends and market position.
By Business
No Data
By Region
No Data
You can ask Aime
Did AVITA Medical beat or miss consensus estimates last quarter?What were the key takeaways from AVITA Medical’s earnings call?What factors drove the changes in AVITA Medical's revenue and profit?What were the key takeaways from AVITA Medical's earnings call?What guidance did AVITA Medical's management provide for the next earnings period?What is the revenue and EPS growth rate for AVITA Medical year over year?What is AVITA Medical's gross profit margin?What is the market's earnings forecast for AVITA Medical next quarter?
ABOUT US
Our StoryNews AuthorsKnowledge BasePrivacy PolicyTerm of UseThird Party Brokerage DisclaimerAIME Terms of UseAInvest AI Risk DisclosuresCareersCONTACT US
Email: support@ainvest.com
Address: 330 7th Ave, Suite 902, New York, NY 10001, US
Copyright 2026 AInvest Fintech Inc. All rights reserved.
